Gestational Diabetes Mellitus (GDM) is a significant health concern, affecting up to 14% of pregnancies worldwide. It not only poses immediate risks to the mother and fetus but also increases the long-term risk of type 2 diabetes and cardiovascular diseases. Hence, optimizing GDM management is crucial.
Early detection and diagnosis of GDM can significantly improve pregnancy outcomes. Universal screening for GDM at 24-28 weeks of gestation using oral glucose tolerance test is recommended. For high-risk women, early screening in the first trimester should be considered.
First-line management of GDM involves lifestyle modifications. A balanced diet rich in fiber and low in simple sugars, along with moderate-intensity exercise for at least 30 minutes a day, can help control blood glucose levels. Regular self-monitoring of blood glucose is also essential.
If lifestyle modifications are insufficient, pharmacological interventions may be required. Insulin therapy is the gold standard for GDM management. However, oral hypoglycemic agents like metformin and glyburide are gaining acceptance due to their convenience and cost-effectiveness.
Postpartum follow-up is vital as GDM increases the risk of developing type 2 diabetes later in life. An oral glucose tolerance test should be performed at 6-12 weeks postpartum. Thereafter, regular screening for diabetes is recommended.
Optimal management of GDM requires a multifaceted approach, including early detection, lifestyle modifications, pharmacological interventions, and postpartum follow-up. By adhering to these strategies, healthcare professionals can significantly improve maternal and fetal outcomes while reducing the long-term risk of type 2 diabetes and cardiovascular diseases.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation